List of largest pharmaceutical mergers and acquisitions
Appearance
The following tabls list the top-9 largest mergers and acquisitions in the pharmaceutical and biotechnology indisutry. Transactions are given in the dollar value for the year of the merger as well as adjusted for inflation.
Rank | Year | Purchaser | Target | Value (in billions USD) |
Value (adjusted for inflation) |
Ref |
---|---|---|---|---|---|---|
1 | 1999 | Pfizer | Warner-Lambert | 90.0 | 165 | [1] |
2 | 2000 | Glaxo Wellcome Plc | SmithKline Beecham Plc. | 76.0 | 134 | |
3 | 2004 | Sanofi | Aventis | 73.5 | 119 | [2] |
4 | 2015 | Actavis | Allergan, Inc | 70.5 | 91 | [3][4][5] |
5 | 2009 | Pfizer | Wyeth | 68.0 | 97 | |
6 | 2002 | Pfizer | Pharmacia | 64.3 | 109 | [2] |
7 | 2009 | Merck & Co. | Schering-Plough | 47.1 | 67 | [6] |
8 | 2014 | Medtronic | Covidien | 42.3 | 54 | |
9 | 2015 | Teva Pharmaceutical Industries | Actavis | 40.5 | 52 |
Pfizer & Allergan
In November 2015 Pfizer announced it would acquire Allergan, Plc for $160 billion. However, this deal was cancelled in April 2016 due to new US tax inversion rules.[7][8] Had this transaction been completed, this would have been the largest within this industry.
See also
References
- ^ http://www.pfizer.ca/english/newsroom/press%20releases/default.asp?s=1&year=2000&releaseID=29
- ^ a b Antoine Gara. "Pfizer And Allergan Merger Ranks As Biggest-Ever Pharmaceutical Deal". Forbes.
- ^ "Allergan Accelerates Transformation to Branded Growth Pharma Leader by Divesting Global Generics Business to Teva for $40.5 Billion". Allergan. 27 July 2015. Retrieved 27 November 2015.
- ^ Koons, Cynthia (27 July 2015). "Teva CEO: $40.5 Billion Allergan Deal is Just the Beginning". Bloomberg. Retrieved 27 November 2015.
- ^ Somayaji, Chitra (27 July 2015). "Teva Snaps Up Allergan's Generics Arm, Dumping Mylan". Bloomberg. Retrieved 27 November 2015.
- ^ "FirstWord Lists – The 20 largest pharma M&Adeals".
- ^ "Pfizer Ends $160B Acquisition of Allergan after U.S. Crackdown on Inversions". GEN.
- ^ "Pfizer, Allergan Agree to End $160 Billion Deal". Bloomberg.com. 6 April 2016.